cancer is a disease in which cancer (malignant) cells are found in the tissues of the thyroid gland. The thyroid gland is at the base of the throat. It has two lobes, one on the right side and one on the left. The thyroid gland makes important hormones that help the body function normally.
Certain factors may increase the risk of developing thyroid cancer.
Thyroid cancer occurs more often in people between the ages of 25 and 65 years.
People who have been exposed to radiation or received radiation treatments to the head and neck during infancy or childhood have a greater chance of developing thyroid cancer. The cancer may occur as early as 5 years after exposure or may occur 20 or more years later.
People who have had goiter (enlarged thyroid) or a family history of thyroid disease have an increased risk of developing thyroid cancer.
Thyroid cancer is more common in women than in men.
Asian people have an increased risk of developing thyroid cancer.
A doctor should be seen if there is a lump or swelling in the front of the neck or in other parts of the neck.
If there are symptoms, a doctor will feel the patient’s thyroid and check for lumps in the neck. The doctor may order blood tests and special scans to see whether a lump in the thyroid is making too many hormones. The doctor may want to take a small amount of tissue from the thyroid. This is called a biopsy. To do this, a small needle is inserted into the thyroid at the base of the throat and some tissue is drawn out. The tissue is then looked at under a microscope to see whether it contains cancer.
There are four main types of thyroid cancer (based on how the cancer cells look under a microscope):
Some types of thyroid cancer grow faster than others. The chance of recovery (prognosis) depends on the type of thyroid cancer, whether it is in the thyroid only or has spread to other parts of the body (stage), and the patient’s age and overall health. The prognosis is better for patients younger than 40 years who have cancer that has not spread beyond the thyroid.
The genes in our cells carry the hereditary information from our parents. An abnormal gene has been found in patients with some forms of thyroid cancer. If medullary thyroid cancer is found, the patient may have been born with a certain abnormal gene which may have led to the cancer. Family members may have also inherited this abnormal gene. Tests have been developed to determine who has the genetic defect long before any cancer appears. It is important that the patient and his or her family members (children, grandchildren, parents, brothers, sisters, nieces and nephews) see a doctor about tests that will show if the abnormal gene is present. These tests are confidential and can help the doctor help patients. Family members, including young children, who don’t have cancer, but do have this abnormal gene, may reduce the chance of developing medullary thyroid cancer by having surgery to safely remove the thyroid gland (thyroidectomy).
Once thyroidcancer is found (diagnosed), more tests will be done to find out if cancer cells have spread to other parts of the body. This is called staging. A doctor needs to know the stage of the disease to plan treatment.
The following stages are used for papillary and follicular thyroid cancer:
In patients younger than 45 years, cancer may have spread within the neck or upper chest and/or to nearby lymph nodes but not to other parts of the body.
In patients aged 45 years and older, the tumor is 2 centimeters (about ¾ inch) or smaller and in the thyroid only.
In patients younger than 45 years, the cancer has spread to distant parts of the body, such as the lung or bone, and may have spread to nearby lymph nodes.
In patients aged 45 years and older, the tumor is larger than 2 centimeters but not larger than 4 centimeters (between ¾ and 1½ inches) in the thyroid only.
The cancer is found in patients aged 45 years or older. The tumor either:
is larger than 4 centimeters; or
may be any size and has spread just outside the thyroid and/or to lymph nodes in the neck.
The cancer is found in patients aged 45 years or older. The tumor may be any size and has spread within the neck and/or to lymph nodes in the neck or upper chest.
The cancer is found in patients aged 45 years or older. The tumor may be any size and has spread to neck tissues near the backbone or around blood vessels in the neck or upper chest. Cancer may have spread to lymph nodes.
The cancer has spread to other parts of the body, such as the lung or bone, and may have spread to nearby lymph nodes.
The following stages are used for medullary thyroid cancer:
No tumor is found in the thyroid but the cancer is detected by screening tests. Stage 0 is also called carcinoma in situ.
The tumor is 2 centimeters or smaller and in the thyroid only.
The tumor is larger than 2 centimeters but not larger than 4 centimeters and is in the thyroid only.
The tumor either:
The tumor may be any size and has spread within the neck and/or to lymph nodes in the neck or upper chest.
The tumor may be any size and has spread to neck tissues near the backbone or around blood vessels in the neck or upper chest. Cancer may have spread to lymph nodes.
Cancer has spread to other parts of the body, such as the lung or bone, and may have spread to nearby lymph nodes.
Anaplastic thyroid cancer is considered to be stage IV thyroid cancer. It grows quickly and has usually spread within the neck when it is found. Anaplastic thyroid cancer develops most often in older people.
Recurrent disease means that the cancer has come back (recurred) after it has been treated. It may come back in the thyroid or in other parts of the body.
There are treatments for all patients with thyroidcancer. Four types of treatment are used:
Surgery (taking out the cancer).
Radiation therapy (using high-dosex-rays or other high-energy rays to kill cancer cells).
Hormone therapy (using hormones to stop cancer cells from growing) .
Chemotherapy (using drugs to kill cancer cells).
Surgery is the most common treatment of thyroid cancer. A doctor may remove the cancer using one of the following operations:
Lobectomy removes only the side of the thyroid where the cancer is found. Lymph nodes in the area may be taken out (biopsied) to see if they contain cancer.
Near-total thyroidectomy removes all of the thyroid except for a small part.
Total thyroidectomy removes the entire thyroid.
Lymph node dissection removes lymph nodes in the neck that contain cancer.
Radiation therapy uses high-energy x-rays to kill cancer cells and shrink tumors.Radiation for thyroid cancer may come from a machine outside the body (external radiation therapy) or from drinking a liquid that contains radioactive iodine. Because the thyroid takes up iodine, the radioactive iodine collects in any thyroid tissue remaining in the body and kills the cancer cells.
Hormone therapy uses hormones to stop cancer cells from growing. In treating thyroid cancer, hormones can be used to stop the body from making other hormones that might make cancer cells grow. Hormones are usually given as pills.
Chemotherapy uses drugs to kill cancer cells. Chemotherapy may be taken by pill, or it may be put into the body by a needle in the vein or muscle. Chemotherapy is called a systemic treatment because the drug enters the bloodstream, travels through the body, and can kill cancer cells outside the thyroid.
Treatment of thyroid cancer depends on the type and stage of the disease, and the patient’s age and overall health.
Standard treatment may be considered because of its effectiveness in patients in past studies, or participation in a clinical trial may be considered. Not all patients are cured with standard therapy and some standard treatments may have more side effects than are desired. For these reasons, clinical trials are designed to find better ways to treat cancer patients and are based on the most up-to-date information. Clinical trials are ongoing in many parts of the country for some patients with thyroid cancer. To learn more about clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237); TTY at 1-800-332-8615.
Treatment may be one of the following:
Surgery to remove the thyroid (total thyroidectomy). This may be followed by hormone therapy and radioactive iodine.
Surgery to remove one lobe of the thyroid (lobectomy), followed by hormone therapy. Radioactive iodine also may be given following surgery.
Surgery to remove the entire thyroid (total thyroidectomy) and lymph nodes where cancer has spread.
Total thyroidectomy followed by radiation therapy with radioactive iodine or external-beam radiation therapy.
External-beam radiation therapy.
Surgery to remove the cancer from places where it has spread.
A clinical trial of new treatments, including chemotherapy.
Treatment may be one of the following:
Total thyroidectomy for tumors in the thyroid only. Lymph nodes in the neck may also be removed.
Radiation therapy for tumors that come back in the thyroid as palliative treatment to relieve symptoms and improve the patient's quality of life.
Chemotherapy for cancer that has spread to other parts of the body, as palliative treatment to relieve symptoms and improve the patient's quality of life.
Surgery to create an opening in the windpipe, for tumors that block the airway. This is called a tracheostomy.
Total thyroidectomy to reduce symptoms if the tumor is in the area of the thyroid only.
Clinical trials of chemotherapy and radiation therapy following thyroidectomy.
Clinical trials studying new methods of treatment of thyroid cancer.
The choice of treatment depends on the type of thyroidcancer the patient has, the kind of treatment the patient had before, and where the cancer comes back. Treatment may be one of the following:
Surgery with or without radioactive iodine. A second surgery may be done to remove tumor that remains.
External-beam radiation therapy or radiation therapy given during surgery to relieve symptoms caused by the cancer.
Clinical trials of new treatments.
The PDQcancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Links to the NCI Dictionary of Cancer Terms were added to this summary.
For more information, U.S. residents may call the National Cancer Institute's (NCI's) Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237) Monday through Friday from 9:00 a.m. to 4:30 p.m. Deaf and hard-of-hearing callers with TTY equipment may call 1-800-332-8615. The call is free and a trained Cancer Information Specialist is available to answer your questions.
Web sites and Organizations
The NCI Web site provides online access to information on cancer, clinical trials, and other Web sites and organizations that offer support and resources for cancer patients and their families. There are also many other places where people can get materials and information about cancer treatment and services. Local hospitals may have information on local and regional agencies that offer information about finances, getting to and from treatment, receiving care at home, and dealing with problems associated with cancer treatment.
The NCI has booklets and other materials for patients, health professionals, and the public. These publications discuss types of cancer, methods of cancer treatment, coping with cancer, and clinical trials. Some publications provide information on tests for cancer, cancer causes and prevention, cancer statistics, and NCI research activities. NCI materials on these and other topics may be ordered online or printed directly from the NCI Publications Locator. These materials can also be ordered by telephone from the Cancer Information Service toll-free at 1-800-4-CANCER (1-800-422-6237), TTY at 1-800-332-8615.
The NCI's LiveHelp service, a program available on several of the Institute's Web sites, provides Internet users with the ability to chat online with an Information Specialist. The service is available from 9:00 a.m. to 11:00 p.m. Eastern time, Monday through Friday. Information Specialists can help Internet users find information on NCI Web sites and answer questions about cancer.
For more information from the NCI, please write to this address:
NCI Public Inquiries Office
6116 Executive Boulevard, MSC8322
Bethesda, MD 20892-8322
PDQ is a comprehensive cancer database available on NCI's Web site.
PDQ is the National Cancer Institute's (NCI's) comprehensive cancer information database. Most of the information contained in PDQ is available online at NCI's Web site. PDQ is provided as a service of the NCI. The NCI is part of the National Institutes of Health, the federal government's focal point for biomedical research.
PDQ contains cancer information summaries.
The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries are available in two versions. The health professional versions provide detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions provide current and accurate cancer information.
The PDQ cancer information summaries are developed by cancer experts and reviewed regularly.
Editorial Boards made up of experts in oncology and related specialties are responsible for writing and maintaining the cancer information summaries. The summaries are reviewed regularly and changes are made as new information becomes available. The date on each summary ("Date Last Modified") indicates the time of the most recent change.
PDQ also contains information on clinical trials.
A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
Listings of clinical trials are included in PDQ and are available online at NCI's Web site. Descriptions of the trials are available in health professional and patient versions. Many cancer doctors who take part in clinical trials are also listed in PDQ. For more information, call the Cancer Information Service 1-800-4-CANCER (1-800-422-6237); TTY at 1-800-332-8615.